Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA npaynter@partners.org.
Nina P
NP
Paynter
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Nancy R
NR
Cook
D015415:Biomarkers / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000378:metabolism; D000066491:Clinical Decision-Making / Q000379:methods*; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D015233:Models, Statistical; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D018570:Risk Assessment / Q000379:methods; D016387:Women's Health / Q000706:statistics & numerical data
D015415:Biomarkers; D008076:Cholesterol, HDL; D006710:Homocysteine